Related Experiment Video
Updated: Feb 15, 2026

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
Published on: June 6, 2025
Effects of Renal Denervation on Cardiac Structural and Functional Abnormalities in Patients with Resistant
Shiying Wang1, Suxia Yang1, Xinxin Zhao1
1Department of Nephrology of Huaihe Hospital of Henan University, Henan Province, China.
Insights
Renal denervation (RDN) showed short-term cardiac improvements in resistant hypertension patients. However, RDN was not superior to intensive drug therapy in improving cardiac remodeling and function long-term.
Area of Science:
- Cardiology
- Nephrology
- Hypertension Research
Background:
- Resistant hypertension (RH) poses significant cardiovascular risks.
- Diastolic dysfunction is a common complication of hypertension.
- Renal denervation (RDN) is an emerging therapy for RH.
Purpose of the Study:
- To systematically evaluate RDN's impact on cardiac structure and function.
- To compare RDN outcomes with pharmaceutical therapy in RH patients.
- To assess changes in left ventricular mass (LVMI) and diastolic function (E/e').
Main Methods:
- Systematic review and meta-analysis of retrieved studies.
- Inclusion of randomized controlled trials (RCTs), controlled, and uncontrolled studies.
- Data extraction on LVMI, E/e', left ventricular ejection fraction (LVEF), and N-terminal pro B-type natriuretic peptide (BNP).
Main Results:
- Observational studies showed reduced LVMI, E/e', and BNP at 6 months post-RDN.
- LV ejection fraction (LVEF) increased at 6 months in observational studies.
- RCTs found no significant difference in LVMI, E/e', BNP, or LVEF at 12 months compared to optimal drug therapy.
Conclusions:
- RDN demonstrated short-term improvements in left ventricular hypertrophy and cardiac function.
- Current evidence does not support RDN's superiority over intensive drug therapy for cardiac remodeling.
- Further research is needed to clarify RDN's long-term efficacy and role in managing resistant hypertension.
Abstract:
The aim of the present study is to systematically evaluate the impact of RDN on cardiac structure and function in patients with resistant hypertension (RH) or diastolic dysfunction. We retrieved Pubmed, Embase and Cocharane Library databases, from inception to April 1st, 2016. Studies reporting left ventricular mass (LVMI) or left ventricular (LV) diastolic function (reflected by the ratio of mitral inflow velocity to annular relaxation velocity [E/e']) responses to RDN were included. Two randomized controlled trials (RCTs), 3 controlled studies and 11 uncontrolled studies were finally identified. In observational studies, there was a reduction in LVMI, E/e' and N-terminal pro B-type natriuretic peptide (BNP) at 6 months, compared with pre-RDN values. LV ejection fraction (LVEF) elevated at 6 months following RDN. In RCTs, however, no significant change in LVMI, E/e', BNP, left atrial volume index or LVEF was observed at 12 months, compared with pharmaceutical therapy. In summary, both LV hypertrophy and cardiac function improved at 6 months after RDN. Nonetheless, current evidence failed to show that RDN was superior to intensive (optimal) drug therapy in improving cardiac remodeling and function.
Related Concept Videos
Structural Protein Function
Collagen, the most abundant protein in mammals, is found throughout the body. In connective tissue, such as skin, ligaments, and tendons, it provides tensile strength and elasticity. In bones and teeth, it mineralizes to...
Structural Protein Function
Structure of Cardiac Muscles
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
Fruit Development, Structure, and Function
Abnormal Proliferation
Structure and Function of Erythrocytes
The erythrocyte plasma membrane is associated with proteins such as spectrin, which forms a flexible cytoplasmic meshwork. This meshwork allows erythrocytes to twist, turn, become cup-shaped, and regain their biconcave shape as they pass through narrow capillaries. Additionally, erythrocytes can form...

